A new breakthrough could prevent the key side effects of popular weight loss drugs such as Ozempic. The drugs also improve ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

A new blood test that can detect Alzheimer's disease in mere minutes has the potential to revolutionise treatment.

An Alzheimer's drug that had been hailed as a major breakthrough may actually increase patients' chance of dying, according to new research. The treatment, lecanemab, was found to triple the risk ...

Oct. 30, 2024 — An important new study has demonstrated ... researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time ...

With diseases such as diabetes, rheumatism or Alzheimer's, by contrast, the aim is to weaken specific aspects of the immune ...

In the US, the Food and Drug Administration (FDA) has yet to grant full approval for blood-based Alzheimer’s tests. Some ...

Alzheimer's disease is the most common cause of dementia in the elderly and is characterized by abnormal deposits of amyloid-beta and tau proteins in the brain. This disease has a ...

Currently on sabbatical at Harvard University, Professor Amal continues to push boundaries in neuroscience while mentoring ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, yet ethical and regulatory challenges persist. These tests raise concerns ...

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, ...